Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer
Fareston (toremifene) and tamoxifen, both selective estrogen receptor modulators, are therapeutically equivalent treatments for metastatic breast cancer. We hypothesized that toremifene as compared with tamoxifen given as adjuvant therapy for early stage breast cancer would result in equivalent surv...
Saved in:
Main Authors: | Jaime D. Lewis, Anees B. Chagpar, Elizabeth A. Shaughnessy, Jacob Nurko, Kelly McMasters, Michael J. Edwards |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-11-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/390 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Estrogen Receptor Expression in Tumors Different from Breast Cancer
by: T. A. Bogush, et al.
Published: (2020-05-01) -
Relation of EGFR/PI3K/AKT signaling components with tamoxifen efficacy in patients with estrogen-dependent breast cancer
by: T. A. Dronova, et al.
Published: (2018-11-01) -
Features of ovarian steroidogenesis and endometrial hypertrophy during adjuvant therapy with tamoxifen in premenopausal patients with hormone-dependent breast cancer
by: A. Yu. Goryainova, et al.
Published: (2023-05-01) -
Tamoxifen Molecular Targets Different From Estrogen Receptors
by: T. A. Bogush, et al.
Published: (2020-05-01) -
Multimodal Imaging of Varied Presentation of Tamoxifen Maculopathy
by: Pushpanjali Badole, et al.
Published: (2025-04-01)